Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Megan V Caram

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Surgical Oncology|November 10, 2011
Advanced or metastatic gastrointestinal stromal tumors: systemic treatment optionsMegan V Caram, Scott M Schuetze
The Journal of Urology|February 3, 2018
Editorial CommentTed A Skolarus, Megan V Caram, Tudor Borza
Current Opinion in Urology|August 22, 2014
Androgen-deprivation-associated bone diseaseTed A Skolarus, Megan V Caram, Vahakn B Shahinian
Urology|January 26, 2019
Impact of Medicare Office Visit Payment Reform on Urologic PracticesParth K Modi, Samuel R Kaufman, Megan V Caram, et al.
Leukemia & Lymphoma|March 6, 2015
Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphomaMegan V Caram, Emily L Bellile, Michael J Englesbe, et al.
JCO Oncology Practice|January 19, 2023
Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment DisparitiesNnenaya Agochukwu-Mmonu, Yongmei Qin, Samuel Kaufman, et al.
Pharmacogenomics|January 23, 2016
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclinesDaniel L Hertz, Megan V Caram, Kelley M Kidwell, et al.
Urologic Oncology|August 19, 2025
Assessing the sex-based enrollment gap in urologic oncology clinical trialsMadison K Krischak, Merrick Bank, Stephanie Daignault-Newton, et al.
Implementation Science Communications|October 29, 2021
Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
Implementation Science Communications|March 21, 2023
Correction: Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Surgical Oncology|November 10, 2011
Advanced or metastatic gastrointestinal stromal tumors: systemic treatment optionsMegan V Caram, Scott M Schuetze
The Journal of Urology|February 3, 2018
Editorial CommentTed A Skolarus, Megan V Caram, Tudor Borza
Current Opinion in Urology|August 22, 2014
Androgen-deprivation-associated bone diseaseTed A Skolarus, Megan V Caram, Vahakn B Shahinian
Urology|January 26, 2019
Impact of Medicare Office Visit Payment Reform on Urologic PracticesParth K Modi, Samuel R Kaufman, Megan V Caram, et al.
Leukemia & Lymphoma|March 6, 2015
Sarcopenia is associated with autologous transplant-related outcomes in patients with lymphomaMegan V Caram, Emily L Bellile, Michael J Englesbe, et al.
JCO Oncology Practice|January 19, 2023
Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment DisparitiesNnenaya Agochukwu-Mmonu, Yongmei Qin, Samuel Kaufman, et al.
Pharmacogenomics|January 23, 2016
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclinesDaniel L Hertz, Megan V Caram, Kelley M Kidwell, et al.
Urologic Oncology|August 19, 2025
Assessing the sex-based enrollment gap in urologic oncology clinical trialsMadison K Krischak, Merrick Bank, Stephanie Daignault-Newton, et al.
Implementation Science Communications|October 29, 2021
Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
Implementation Science Communications|March 21, 2023
Correction: Learning from the "tail end" of de-implementation: the case of chemical castration for localized prostate cancerTed A Skolarus, Jane Forman, Jordan B Sparks, et al.
Pageof 2